Pfizer Forks Over $894 Million To Settle Celebrex/Bextra Litigation
This article was originally published in The Pink Sheet Daily
Executive Summary
Agreement represents less than half of the firm’s annual Celebrex sales.
You may also be interested in...
Allergan Under Investigation By Oregon For Deceptive Promotions
State effort is focused on one unnamed drug but may expand; the company is already facing a federal inquiry about off-label promotion of Botox for headache treatment.
Allergan Under Investigation By Oregon For Deceptive Promotions
State effort is focused on one unnamed drug but may expand; the company is already facing a federal inquiry about off-label promotion of Botox for headache treatment.
Pfizer Settlement Means New Oversight; Does It Mean A New Marketing Plan?
The government may be hoping the third time's the charm as it enters into a new corporate integrity agreement with Pfizer